CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 47 filers reported holding CLEARSIDE BIOMEDICAL INC in Q3 2023. The put-call ratio across all filers is 1.66 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1 | -50.0% | 2,000 | 0.0% | 0.00% | – |
Q2 2023 | $2 | 0.0% | 2,000 | 0.0% | 0.00% | – |
Q1 2023 | $2 | 0.0% | 2,000 | 0.0% | 0.00% | – |
Q4 2022 | $2 | -99.9% | 2,000 | 0.0% | 0.00% | – |
Q3 2022 | $2,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
Q2 2022 | $2,000 | -50.0% | 2,000 | 0.0% | 0.00% | – |
Q1 2022 | $4,000 | -20.0% | 2,000 | -4.8% | 0.00% | – |
Q4 2021 | $5,000 | -58.3% | 2,100 | -32.3% | 0.00% | -100.0% |
Q3 2021 | $12,000 | -47.8% | 3,100 | -80.7% | 0.00% | 0.0% |
Q2 2021 | $23,000 | +1050.0% | 16,100 | +1138.5% | 0.00% | – |
Q2 2020 | $2,000 | 0.0% | 1,300 | 0.0% | 0.00% | – |
Q1 2020 | $2,000 | -33.3% | 1,300 | 0.0% | 0.00% | – |
Q4 2019 | $3,000 | – | 1,300 | 0.0% | 0.00% | – |
Q3 2019 | $0 | -100.0% | 1,300 | 0.0% | 0.00% | – |
Q2 2019 | $1,000 | 0.0% | 1,300 | 0.0% | 0.00% | – |
Q1 2019 | $1,000 | 0.0% | 1,300 | 0.0% | 0.00% | – |
Q4 2018 | $1,000 | -98.8% | 1,300 | -91.6% | 0.00% | -100.0% |
Q2 2018 | $84,000 | +833.3% | 15,400 | +1611.1% | 0.01% | +600.0% |
Q1 2018 | $9,000 | – | 900 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACT CAPITAL MANAGEMENT, LLC | 2,462,500 | $11,993,000 | 6.16% |
ACUTA CAPITAL PARTNERS, LLC | 1,316,268 | $6,410,000 | 2.56% |
AJU IB Investment Co., Ltd. | 293,555 | $1,430,000 | 0.82% |
RTW INVESTMENTS, LP | 4,206,765 | $20,487,000 | 0.31% |
Carmignac Gestion | 3,419,877 | $16,655,000 | 0.19% |
EAM Investors, LLC | 247,561 | $1,206,000 | 0.19% |
Curi Wealth Management, LLC | 25,000 | $121,000 | 0.06% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 316,600 | $1,542,000 | 0.03% |
TWO SIGMA ADVISERS, LP | 990,000 | $4,821,000 | 0.01% |
CAXTON ASSOCIATES LP | 24,677 | $120,000 | 0.01% |